Cargando…

Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.

Estraumustine phosphate (EMP), a cytotoxic drug used in the treatment of prostatic carcinoma, has been shown to exert cytotoxic effects on glioma cells in vitro. The drug uptake is assumed to depend on a specific estramustine binding protein (EMBP). One of the main difficulties in achieving cytotoxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergenheim, A. T., Gunnarsson, P. O., Edman, K., von Schoultz, E., Hariz, M. I., Henriksson, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968176/ https://www.ncbi.nlm.nih.gov/pubmed/8431366

Ejemplares similares

Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
por: von Schoultz, E., et al.
Publicado: (1988)

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma
por: Johansson, M, et al.
Publicado: (1999)

DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.
por: Vallbo, C., et al.
Publicado: (1995)

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience
por: Nakano, Kazuhiko, et al.
Publicado: (2012)

Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer
por: Albrecht, W, et al.
Publicado: (2004)

Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.
por: Behnam-Motlagh, P., et al.
Publicado: (1997)

Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
por: Speicher, L. A., et al.
Publicado: (1991)

Comparison of Ketoconazole and Estramustine for Treating Patients with Castration-Resistant Prostate Cancer
por: Yun, Bu Hyeon, et al.
Publicado: (2011)

Marked leukocytosis in response to estramustine phosphate in a hormone-refractory prostate cancer patient
por: Morita, Tatsuo
Publicado: (2010)

Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
por: Hernes, E. H., et al.
Publicado: (1997)

Chemotherapy with or without estramustine for treatment of castration-resistant prostate cancer: A systematic review and meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2016)

Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells
Publicado: (1988)

Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production
por: Mojsilovic, Sonja S., et al.
Publicado: (2018)

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer
por: Galli, L, et al.
Publicado: (2007)

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
por: Carles, J, et al.
Publicado: (2007)

A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899
por: DiPaola, Robert S, et al.
Publicado: (2010)

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2012)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000)

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
por: Wibom, C, et al.
Publicado: (2006)

Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
por: Wibom, C, et al.
Publicado: (2006)

The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model
por: Sandström, M, et al.
Publicado: (2004)

Brain uptake, retention, and efflux of aluminum and manganese.
por: Yokel, Robert A
Publicado: (2002)

Segmental demyelination of peripheral nerves in the presence of malignant tumours.
por: Kashef, R., et al.
Publicado: (1967)

“Malignant Brain Tumours.”
por: Byrnes, D P
Publicado: (1996)

Selective peripheral denervation for cervical dystonia: long-term follow-up
por: Bergenheim, A Tommy, et al.
Publicado: (2015)

Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma
por: Mao, Feng, et al.
Publicado: (2018)

The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts.
por: Sparrow, S., et al.
Publicado: (1986)

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
por: Melis, Marleen, et al.
Publicado: (2009)

In vivo uptake of labelled oestradiol by benign and malignant tumours of the human breast.
por: O'Higgins, N. J., et al.
Publicado: (1973)

Uptake and Retention of Nanoplastics in Quagga Mussels
por: Merzel, Rachel L., et al.
Publicado: (2019)

UPTAKE AND RETENTION OF FIXED CARBON IN ADULT MICE
por: Buchanan, Donald L.
Publicado: (1951)

The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour
por: Teich, Niels, et al.
Publicado: (2005)

Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study.
por: Yoshida, D., et al.
Publicado: (1998)

Sinus lifts in the presence of pseudoantral and mucous retention cysts
por: Choi, Moon Gi, et al.
Publicado: (2022)

In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in man.
por: Philip, P. A., et al.
Publicado: (1991)

The Uptake of Proteins by Normal and Tumour Cells In Vitro
por: Easty, G. C., et al.
Publicado: (1964)

Malignant Brain Tumours in Children : Present and Future Perspectives
por: Rutka, James T.
Publicado: (2018)

A Neurocysticercosis Infestation Masquerading as Malignant Brain Tumour
por: Gupta, Madan Mohan, et al.
Publicado: (2021)

Observations on the binding of testosterone to malignant mammary tumours and other tissues in vitro.
por: Braunsberg, H., et al.
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_gls4094r6us3v67i0ubctdmbvl